Skip to main content
. 2013 Feb 1;33(2):e00019. doi: 10.1042/BSR20110124

Figure 6. MSC–PEDF administration is associated with decreased tumour angiogenesis.

Figure 6

Glioma vascularization was determined by staining with anti-CD34 antibody after MSC or MSC–PEDF treatment. Decreased density of vessels was observed in tumours from MSC–PEDF-treated mice (C) (*P<0.05). In contrast, a mass of vessels were seen in MSCs (A) and PBS groups (B). (Original magnification ×200)